Moderna says it can produce 94.5% of the vaccine against COVID-19

In addition, over the next year, both companies could produce a billion doses of the vaccine. It is possible that both companies may be using new technology known as messenger RNA or mRNA to produce vaccines.

The Pfizer vaccine must be transported and stored at -70 ° C, the same cold as the Arctic cold. While if kept in the refrigerator, it will only keep 5 days .

Some 30,000 people participated in the trial, Moderna data showed, reflecting the vaccine to prevent COVID-19, while Pfizer’s vaccine data is unclear. About 95 people found that about 11 were severely ill and the drug did not affect treatment, and of the 95 people who were tested there were different groups of people, 15 of whom were seniors aged 65. The more senior and there are 20 people of different races.

Moderna is another part of the U.S. Operation Warp Speed ​​program, which is expected to produce around 20 million doses of the vaccine this year.Moderna has received around $ 1 billion in research and development funding for the vaccine.

United States According to the agreement, 100 million doses would have been produced and would be worth US $ 1.5 billion. The company expects that the vaccine will be 500-1 billion doses by 2021, both in the US. And abroad Depend on demand.

To tackle the ongoing COVID outbreak. To happen In the midst of news, the two companies in the United States and Europe have begun increasing the coronavirus outbreak, leading to another lockdown.

Stephen Hoge, President of Moderna, told the phone: “We are producing a vaccine that can stop the spread of COVID-19.”

The CNA reports that the vaccines made with Moderna do not need to be kept at ultra-cold temperatures like those Pfizer makes, which may make it easier to distribute, and Moderna expects the vaccine to be refrigerated at a temperature. At 2-8 ° C for 30 days and may be stored for up to 6 months if kept at -2 ° C. 

Drug giant Moderna has released a report on the results of its vaccine trial. It was found to protect against COVID-19 by 94.5%, the second after Pfizer previously disclosed that the vaccine was able to fight more than 90% of COVID-19. 

good news! Pfizer reveals the company’s vaccine against COVID-19 has more than 90% of the time.

Moderna is the second company to report results of the vaccine trial. It is likely that both Pfizer and Moderna will become American vaccine companies that can be used as an emergency release by December, around 60 million doses.